Utilizing Information System to Tackle Drug-Drug Interaction in Clinical Setting

Abstract

Drug interaction, in particular drug-drug interaction (DDI), is one of the contributors of medication errors and adverse drug event incidence. DDI, although a preventable cause of medication error, were found to cause at least 30% of ADE in Pennsylvania, USA (Grissinger 2016). In Indonesia. DDI incident was also found to reached above 50% in one of the teaching hospital in Java (Rahmawati et al. 2006). Preventing medication error and adverse drug event caused by drug interaction can be done by utilizing information technology and information system in healthcare practice. Many organizations have come out with a website or application for drug interaction checkers, such as IBM Micromedex®, Drugs.com, DrugBank, and Medscape. Unfortunately, some application or website is a paid service if healthcare practice wants to incorporate

it to their electronic prescribing system with high subscription cost. In addition, those application and website not catered to drugs available in Indonesia, posing anoth This book was made to document the steps that we have taken to come up with innovative idea to tackle the DDI problems found in the hospital utilizing the experts in academia and the local hospital. This book contains step by step explanations on how to make innovation from drug-drug interaction problems in clinical practice in Indonesia. We hope that this book can inspire students to identify problems in healthcare and think of innovation to solve the problems. We also hoped through this book, students will be familiar with the strategies and steps that needs to be taken to implement the innovation idea that students have come up with. Lastly, we would like to express our appreciation to Lira Medika Hospital and Indonesia International Institute for life sciences for their continuous support in the implementation of the program. We also would like to thank the Ministry of Education, Culture, Research, and Technology of Indonesia for the funding of the program as a part of the Matching Fund scheme: 3717/E3/SPMK.08/KL/2021.